Press Releases

ST. LOUIS, Feb. 13, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will provide its consolidated 2020 annual guidance, including WellCare Health Plans, Inc. (WellCare), after the close of trading on Tuesday, March 3, 2020, and host a conference call on Wednesday, March 4, 202

ATLANTA, Feb. 13, 2020 /PRNewswire/ -- Advanced Medical Pricing Solutions (AMPS), the pioneer in cost containment for the self-insurance industry, today announced

MOUNTAIN VIEW, Calif., Feb. 13, 2020 /PRNewswire/ -- As part of its continued global expansion, Glooko, the leader in diabetes digital health and data management solutions, today announced the appointment of Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer. Henderson joins Glooko with extensive ex

TORONTO and HOUSTON, Feb. 13, 2020 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today reported financial results for the three and nine months ended December 31, 2019. The Company's fiscal Q3 2020

BALTIMORE, Feb. 13, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, will announce financial results for the fourth quarter and full year ended December 31, 2019 on Wednesday, February 26, 2020, after market close.

Net Revenue of $66.6 million, excluding provisions of $10.6 million Net Cannabis Revenue, excluding provisions, of $63.2 million, In Line With Recent Guidance Cash Cost to Produce Per Gram Sold of $0.88 Successful Launch of

DUBLIN, Feb. 13, 2020 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its fourth quarter and full year 2019 financial and operating results and provide a business update after market close on

PRINCETON, N.J., Feb. 13, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its RiVax® (heat stable ricin toxin vaccine) development program for preve

CAMBRIDGE, Mass., Feb. 13, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2019.

DUBLIN, Feb. 13, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter and year ended Dec. 31, 2019 and provided financ